Cannabis oil trial aims to tame seizures in rare genetic disorder
Disease control
Recruiting now
This Phase 3 trial tests a full-spectrum cannabis extract (YCJ-01) in 84 people aged 2 to 65 with tuberous sclerosis complex (TSC) whose seizures have not been controlled by standard treatments. Participants will receive either the cannabis extract or a placebo for two months. Th…
Phase: PHASE3 • Sponsor: Oils4Cure • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC